Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025
Provided By GlobeNewswire
Last update: Aug 11, 2025
COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.
Read more at globenewswire.com
